医学
怀孕
药品
抗甲状腺药物
抗甲状腺药
不利影响
药物治疗
重症监护医学
儿科
内分泌学
内科学
格雷夫斯病
生物信息学
药理学
疾病
生物
遗传学
作者
Henry B. Burch,David S. Cooper
出处
期刊:European journal of endocrinology
[Bioscientifica]
日期:2018-11-01
卷期号:179 (5): R261-R274
被引量:95
摘要
The thionamide antithyroid drugs were discovered in large part following serendipitous observations by a number of investigators in the 1940s who found that sulfhydryl-containing compounds were goitrogenic in animals. This prompted Prof. Edwin B Astwood to pioneer the use of these compounds to treat hyperthyroidism in the early 1940s and to develop the more potent and less toxic drugs that are used today. Despite their simple molecular structure and ease of use, many uncertainties remain, including their mechanism(s) of action, clinical role, optimal use in pregnancy and the prediction and prevention of rare but potentially life-threatening adverse reactions. In this review, we summarize the history of the development of these drugs and outline their current role in the clinical management of patients with hyperthyroidism.
科研通智能强力驱动
Strongly Powered by AbleSci AI